| Marcia P Taborga, PHD | |
|
3350 E Birch St, Brea, CA 92821-6264 | |
| (562) 431-8822 | |
| (562) 431-8875 |
| Full Name | Marcia P Taborga |
|---|---|
| Gender | Female |
| Speciality | Psychologist - Clinical |
| Location | 3350 E Birch St, Brea, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396297313 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC0700X | Psychologist - Clinical | PSY 21086 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Marcia P Taborga, PHD 417 S Associated Rd # 433, Brea, CA 92821-5802 Ph: (213) 915-6093 | Marcia P Taborga, PHD 3350 E Birch St, Brea, CA 92821-6264 Ph: (562) 431-8822 |
News Archive
Ahmad M. Khalil, PhD, knew the odds were against him - as in thousands upon thousands to one. Yet he and his team never wavered from their quest to identify the parts of the body responsible for revving up one of the most aggressive forms of breast cancer, HER2+. This month in Breast Cancer Research and Treatment, Khalil and his colleagues at Case Western Reserve University proved the power of persistence; from a pool of more than 30,000 possibilities, they found 38 genes and molecules that most likely trigger HER2+ cancer cells to spread.
Cases of the highly contagious, drug-resistant bacteria, carbapenem-resistant Enterobacteriaceae (CRE), have increased fivefold in community hospitals in the Southeastern United States, according to a new study published in the August issue of Infection Control and Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America.
Scientists at the Universities of Birmingham and Amsterdam hope to have found a new neurobiological marker to help recognize patients with post-traumatic stress disorder (PTSD).
Anacor Pharmaceuticals (NASDAQ:ANAC) announced today that its abstract "Pivotal Phase 3 Safety and Efficacy Results of Tavaborole (Formerly AN2690), a Novel Boron-Based Molecule for the Topical Treatment of Toenail Onychomycosis" was accepted for oral presentation at the 2013 APMA Annual Scientific Meeting (The National) to be held in Las Vegas, Nevada.
Medivation, Inc. (Nasdaq: MDVN) today announced treatment of the first patient in a Phase 3 clinical trial of the investigational drug MDV3100 in advanced prostate cancer. Known as AFFIRM, the trial will evaluate the novel androgen receptor antagonist MDV3100 in men with castration-resistant prostate cancer who were previously treated with docetaxel-based chemotherapy.
› Verified 6 days ago
Sarwat Bashir Waraich, PSY.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 135 S State College Blvd Ste 200, Brea, CA 92821 Phone: 626-283-5852 Fax: 626-280-3110 | |
Dr. Hong Yee, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1220 Baywood Dr, Brea, CA 92821 Phone: 408-464-7492 | |
Dr. Jaime Humberto Brown Jr., PSY. D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 265 S Randolph Ave Ste 165, Brea, CA 92821 Phone: 626-581-6752 Fax: 714-544-1473 | |
Dr. Suranee Waleszonia, PH.D. Psychologist Medicare: Medicare Enrolled Practice Location: 135 S State College Blvd Ste 200, Brea, CA 92821 Phone: 714-745-6850 | |
Dr. Roxie Robin Persi, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 242 S Orange Ave, Suite 202, Brea, CA 92821 Phone: 714-985-0390 Fax: 714-672-9405 | |
Dr. Jim S Grimes, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1215 W Imperial Hwy Ste 207, Brea, CA 92821 Phone: 714-496-7955 | |
Dr. Vicki Kaye Harvey, PSY.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 238 S Orange Ave Ste 206, Brea, CA 92821 Phone: 714-529-5712 |